Since 2018, there has been an exponential growth of over US$60 billion of licensing deals involving Antibody Drug Conjugates (ADCs), with 2023 having at least 18 deals. ADCs worldwide are projected to reach US$20-30 billion per year in the near future.
鶹ֱ’s Health Care & Life Sciences and Innovative Technology sectors invite you to join us for a webinar on how your organization can navigate the crossroads of ADCs and how you can prepare for this evolving landscape.
This webinar will explore the following:
• An inside look on the U.S. Food & Drug Administration’s (FDA) perspective on ADCs.
• How to prepare and secure your patents and safeguard your ADC intellectual property.
• The do’s and don’ts of an ADC merger and acquisition.
• Litigation trends in the ADC industry.
• Clinical trial considerations for ADCs.
To watch the recording of this webinar, please click .
